Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prisys Biotech
Shanghai, Shanghai, Chinaprisysbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Prisys Biotech is a leading CRO specializing in non-human primate pharmacology and translational medicine platforms. The company enables global biopharma clients to bridge the gap between preclinical discovery and clinical development by providing robust NHP disease models for efficacy/safety/pharmacokinetics/toxicology studies across major therapeutic areas. Their platform is AAALAC-accredited with state-of-the-art facilities in Shanghai. They do not have their own drug candidates but support the advancement of client pipelines with high-quality data packages for IND-enabling studies[1][3].
- Therapeutic areas
- NeurologyMetabolic DisordersPsychiatryOphthalmologyHematologyOncologyImmunology
- Modalities
- Antibody-drug conjugateGene therapySmall moleculeRNA therapy (including small interfering RNA, antisense oligonucleotide, microRNA)
- Industry
- Contract Research Organization
02
Partnerships
Prisys collaborates widely with domestic and international pharmaceutical companies on co-development projects involving NHP model validation of new drugs—specific partner names are not disclosed publicly[5].
Beyond the preview
Go deeper on Prisys Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prisys Biotech.